Alcohol Use During Chemotherapy: A Pilot Study.

Area of Science:

• Oncology
• Public Health
• Cancer Survivorship

Background:

• Alcohol consumption is a known risk factor for cancer development and can complicate treatment.
• Limited data exists on the prevalence of alcohol use among patients undergoing chemotherapy.
• This pilot study addresses this gap by examining alcohol use during chemotherapy in cancer survivors.

Purpose of the Study:

• To investigate the prevalence of self-reported alcohol consumption during chemotherapy among cancer survivors.
• To identify potential risk factors associated with alcohol use during this critical treatment period.
• To lay the groundwork for future research and the development of targeted interventions.

Main Methods:

• A pilot study surveyed 69 cancer survivors from the Survey of the Health of Wisconsin (SHOW) study.
• Participants reported on their alcohol consumption patterns while undergoing chemotherapy.
• Statistical analysis, including rate ratios (RR) and 95% confidence intervals (CI), was used to identify associations.

Main Results:

• 30.4% of cancer survivors reported consuming alcohol during chemotherapy.
• Among those who drank, 38.1% experienced complications.
• Alcohol use was more common in older adults (65+), men, current/former smokers, and those with non-alcohol-related cancers.

Conclusions:

• Alcohol use during chemotherapy is a common occurrence among cancer survivors.
• This behavior may be linked to an increased risk of treatment complications.
• Further research is essential to understand the full scope of this issue and to develop effective interventions.